Compare NAGE & ELLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NAGE | ELLO |
|---|---|---|
| Founded | 1999 | 1987 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 239.0M | 255.4M |
| IPO Year | 2010 | 1998 |
| Metric | NAGE | ELLO |
|---|---|---|
| Price | $3.11 | $20.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 538.1K | 2.3K |
| Earning Date | 05-06-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 81.82 | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $129,423,000.00 | N/A |
| Revenue This Year | $16.51 | N/A |
| Revenue Next Year | $14.58 | N/A |
| P/E Ratio | $35.22 | ★ N/A |
| Revenue Growth | ★ 29.95 | N/A |
| 52 Week Low | $2.87 | $17.00 |
| 52 Week High | $10.52 | $30.34 |
| Indicator | NAGE | ELLO |
|---|---|---|
| Relative Strength Index (RSI) | 45.35 | 54.45 |
| Support Level | $2.91 | $17.79 |
| Resistance Level | $3.61 | $22.58 |
| Average True Range (ATR) | 0.11 | 0.83 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 43.42 | 75.64 |
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
Ellomay Capital Ltd is a renewable energy company. It develops and operates renewable energy projects in Europe, the USA, and Israel, employing diverse technologies such as solar power, natural gas, pumped hydro, and waste-to-energy solutions. Geographically, the company operates in segments: Italy; Spain; USA; Netherland and Israel. It derives maximum revenue from Spain.